0000899243-20-002026.txt : 20200127 0000899243-20-002026.hdr.sgml : 20200127 20200127145846 ACCESSION NUMBER: 0000899243-20-002026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200123 FILED AS OF DATE: 20200127 DATE AS OF CHANGE: 20200127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McDonough John CENTRAL INDEX KEY: 0001615937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 20549113 MAIL ADDRESS: STREET 1: T2 BIOSYSTEMS, INC. STREET 2: 101 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-23 0 0001492674 T2 Biosystems, Inc. TTOO 0001615937 McDonough John 101 HARTWELL AVE LEXINGTON MA 02421 1 0 0 0 Common Stock 2020-01-23 4 S 0 57417 1.15 D 512868 D The transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 11, 2018. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.10 to $1.20. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ John Sprague, Attorney-in-fact 2020-01-27